id,name,source,license,url,description,chromosome,inchikey,inchi,mesh_id,bto_id,class_type
N0000007632,Thyroxine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007632,,,,,,,Chemical/Ingredient
N0000011272,Thiazolidinediones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011272,,,,,,,Chemical/Ingredient
N0000178477,Decreased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178477,,,,,,,Physiologic Effect
N0000010288,Osmotic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010288,,,,,,,Mechanism of Action
N0000190114,Cytochrome P450 3A Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190114,,,,,,,Mechanism of Action
N0000175799,Dopamine D2 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175799,,,,,,,Mechanism of Action
N0000000114,Dopamine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000114,,,,,,,Mechanism of Action
N0000175732,Neuromuscular Nondepolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175732,,,,,,,Physiologic Effect
N0000175729,Central Nervous System Stimulation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175729,,,,,,,Physiologic Effect
N0000008779,Decreased Parasympathetic Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008779,,,,,,,Physiologic Effect
N0000007618,Ergolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007618,,,,,,,Chemical/Ingredient
N0000175654,Gonadotropin Releasing Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175654,,,,,,,Mechanism of Action
N0000167094,Benzothiazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167094,,,,,,,Chemical/Ingredient
N0000020024,Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020024,,,,,,,Mechanism of Action
N0000175379,Arteriolar Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175379,,,,,,,Physiologic Effect
N0000175764,Serotonin 1d Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175764,,,,,,,Mechanism of Action
N0000175914,Increased Coagulation Factor VIII Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175914,,,,,,,Physiologic Effect
N0000007151,Folic Acid,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007151,,,,,,,Chemical/Ingredient
N0000008053,Sulfones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008053,,,,,,,Chemical/Ingredient
N0000191267,Cytochrome P450 2D6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191267,,,,,,,Mechanism of Action
N0000175089,Calcium Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175089,,,,,,,Mechanism of Action
N0000008486,Decreased Central Nervous System Disorganized Electrical Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008486,,,,,,,Physiologic Effect
N0000008479,Decreased Cell Wall Synthesis & Repair,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008479,,,,,,,Physiologic Effect
N0000009947,Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009947,,,,,,,Mechanism of Action
N0000009176,Increased Cellular Death,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009176,,,,,,,Physiologic Effect
N0000011281,Penicillins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011281,,,,,,,Chemical/Ingredient
N0000000070,Angiotensin 2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000070,,,,,,,Mechanism of Action
N0000175087,Urease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175087,,,,,,,Mechanism of Action
N0000185007,Adrenergic beta3-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185007,,,,,,,Mechanism of Action
N0000000083,Leukotriene Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000083,,,,,,,Mechanism of Action
N0000191264,P-Glycoprotein Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191264,,,,,,,Mechanism of Action
N0000011414,Ketolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011414,,,,,,,Chemical/Ingredient
N0000007647,Nitrates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007647,,,,,,,Chemical/Ingredient
N0000187062,Cytochrome P450 2C8 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187062,,,,,,,Mechanism of Action
N0000006277,Vitamin D,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006277,,,,,,,Chemical/Ingredient
N0000191272,UGT1A1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191272,,,,,,,Mechanism of Action
N0000175915,Increased Coagulation Factor VIII Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175915,,,,,,,Physiologic Effect
N0000175960,Increased Glutathione Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175960,,,,,,,Physiologic Effect
N0000008953,Decreased Striated Muscle Contraction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008953,,,,,,,Physiologic Effect
N0000010262,Neurokinin 1 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010262,,,,,,,Mechanism of Action
N0000009282,Increased Dopamine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009282,,,,,,,Physiologic Effect
N0000182138,Cytochrome P450 1A2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182138,,,,,,,Mechanism of Action
N0000175359,Increased Diuresis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175359,,,,,,,Physiologic Effect
N0000187063,Cytochrome P450 2C8 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187063,,,,,,,Mechanism of Action
N0000175512,Methylated Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175512,,,,,,,Chemical/Ingredient
N0000190111,Organic Anion Transporter 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190111,,,,,,,Mechanism of Action
N0000006999,Urea,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006999,,,,,,,Chemical/Ingredient
N0000191265,Organic Cation Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191265,,,,,,,Mechanism of Action
N0000000160,Cyclooxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000160,,,,,,,Mechanism of Action
N0000000151,Histamine H2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000151,,,,,,,Mechanism of Action
N0000007544,Phenothiazines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007544,,,,,,,Chemical/Ingredient
N0000009948,Non-Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009948,,,,,,,Mechanism of Action
N0000007715,Catecholamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007715,,,,,,,Chemical/Ingredient
N0000005760,Aminosalicylic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005760,,,,,,,Chemical/Ingredient
N0000175516,RNA Synthetase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175516,,,,,,,Mechanism of Action
N0000171207,Porphyrinogens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171207,,,,,,,Chemical/Ingredient
N0000008859,Decreased Renal K+ Excretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008859,,,,,,,Physiologic Effect
N0000009371,Increased Large Intestinal Motility,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009371,,,,,,,Physiologic Effect
N0000009963,Thrombin Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009963,,,,,,,Mechanism of Action
N0000000116,GABA B Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000116,,,,,,,Mechanism of Action
N0000008832,Decreased Platelet Aggregation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008832,,,,,,,Physiologic Effect
N0000007659,Nitrogen Mustard Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007659,,,,,,,Chemical/Ingredient
N0000000115,Progestational Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000115,,,,,,,Mechanism of Action
N0000008836,Decreased Prostaglandin Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008836,,,,,,,Physiologic Effect
N0000184306,Cell-mediated Immunity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184306,,,,,,,Physiologic Effect
N0000010259,Ultrasound Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010259,,,,,,,Mechanism of Action
N0000008683,Decreased Leukotriene Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008683,,,,,,,Physiologic Effect
N0000175830,Inhibit Ovum Fertilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175830,,,,,,,Physiologic Effect
N0000175080,Aromatase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175080,,,,,,,Mechanism of Action
N0000187064,Cytochrome P450 2B6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187064,,,,,,,Mechanism of Action
N0000175967,Thrombopoietin Receptor Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175967,,,,,,,Mechanism of Action
N0000000235,Carbonic Anhydrase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000235,,,,,,,Mechanism of Action
N0000006269,Vitamin A,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006269,,,,,,,Chemical/Ingredient
N0000007909,Psoralens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007909,,,,,,,Chemical/Ingredient
N0000175921,Adrenal Steroid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175921,,,,,,,Mechanism of Action
N0000007529,Macrolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007529,,,,,,,Chemical/Ingredient
N0000006996,Cholecalciferol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006996,,,,,,,Chemical/Ingredient
N0000009911,Venous Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009911,,,,,,,Physiologic Effect
N0000185499,Guanylate Cyclase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185499,,,,,,,Mechanism of Action
N0000000146,Androgen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000146,,,,,,,Mechanism of Action
N0000006496,Nicotine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006496,,,,,,,Chemical/Ingredient
N0000175808,Hydroxyphenylpyruvate Dioxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175808,,,,,,,Mechanism of Action
N0000175728,Central Nervous System Depression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175728,,,,,,,Physiologic Effect
N0000007641,Nicotinic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007641,,,,,,,Chemical/Ingredient
N0000007568,Oxazolidinones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007568,,,,,,,Chemical/Ingredient
N0000175850,Melanin Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175850,,,,,,,Mechanism of Action
N0000190482,Phenylalanine Hydroxylase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190482,,,,,,,Mechanism of Action
N0000170119,PPAR gamma,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170119,,,,,,,Chemical/Ingredient
N0000009456,Increased Norepinephrine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009456,,,,,,,Physiologic Effect
N0000000206,Xanthine Oxidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000206,,,,,,,Mechanism of Action
N0000009871,Stimulation Large Intestine Fluid/Electrolyte Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009871,,,,,,,Physiologic Effect
N0000009724,Inhibition Gastric Acid Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009724,,,,,,,Physiologic Effect
N0000000183,Acetyl Aldehyde Dehydrogenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000183,,,,,,,Mechanism of Action
N0000009269,Increased Cytokine Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009269,,,,,,,Physiologic Effect
N0000175073,Platinum-containing Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175073,,,,,,,Chemical/Ingredient
N0000000207,Histamine Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000207,,,,,,,Mechanism of Action
N0000175817,Serotonin 3 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175817,,,,,,,Mechanism of Action
N0000175635,Factor Xa Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175635,,,,,,,Mechanism of Action
N0000007822,Polymyxins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007822,,,,,,,Chemical/Ingredient
N0000007542,Benzodiazepines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007542,,,,,,,Chemical/Ingredient
N0000006801,Bile Acids and Salts,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006801,,,,,,,Chemical/Ingredient
N0000009801,Photosensitizing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009801,,,,,,,Physiologic Effect
N0000000102,Norepinephrine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000102,,,,,,,Mechanism of Action
N0000191280,Lipoglycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191280,,,,,,,Chemical/Ingredient
N0000009526,Increased Prostaglandin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009526,,,,,,,Physiologic Effect
N0000011310,Aldosterone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011310,,,,,,,Mechanism of Action
N0000000154,Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000154,,,,,,,Mechanism of Action
N0000007196,Iodine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007196,,,,,,,Chemical/Ingredient
N0000182137,Cytochrome P450 2D6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182137,,,,,,,Mechanism of Action
N0000007522,Allylamine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007522,,,,,,,Chemical/Ingredient
N0000020081,Increased Calcium-sensing Receptor Sensitivity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020081,,,,,,,Mechanism of Action
N0000175755,DOPA Decarboxylase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175755,,,,,,,Mechanism of Action
N0000191274,UGT2B15 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191274,,,,,,,Mechanism of Action
N0000007780,Vinca Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007780,,,,,,,Chemical/Ingredient
N0000175450,Corticosteroid Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175450,,,,,,,Mechanism of Action
N0000000150,Protein Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000150,,,,,,,Mechanism of Action
N0000175686,Competitive Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175686,,,,,,,Mechanism of Action
N0000000174,Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000174,,,,,,,Mechanism of Action
N0000006688,Carnitine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006688,,,,,,,Chemical/Ingredient
N0000175375,Peroxisome Proliferator-activated Receptor alpha Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175375,,,,,,,Mechanism of Action
N0000010217,Photoabsorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010217,,,,,,,Mechanism of Action
N0000175788,Adenosine Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175788,,,,,,,Mechanism of Action
N0000175644,Decreased Autonomic Ganglionic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175644,,,,,,,Physiologic Effect
N0000184148,Smoothened Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184148,,,,,,,Mechanism of Action
N0000175763,Serotonin 1b Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175763,,,,,,,Mechanism of Action
N0000009905,Vascular Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009905,,,,,,,Physiologic Effect
N0000175075,Proteasome Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175075,,,,,,,Mechanism of Action
N0000007698,Biguanides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007698,,,,,,,Chemical/Ingredient
N0000009393,Increased Medullary Respiratory Drive,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009393,,,,,,,Physiologic Effect
N0000008016,Barbiturates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008016,,,,,,,Chemical/Ingredient
N0000190109,Organic Anion Transporting Polypeptide 2B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190109,,,,,,,Mechanism of Action
N0000000104,Cholinergic Muscarinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000104,,,,,,,Mechanism of Action
N0000008065,Purines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008065,,,,,,,Chemical/Ingredient
N0000180999,Angiotensin 2 Type 1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000180999,,,,,,,Mechanism of Action
N0000175086,Phosphodiesterase 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175086,,,,,,,Mechanism of Action
N0000175970,Increased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175970,,,,,,,Physiologic Effect
N0000191278,UGT1A9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191278,,,,,,,Mechanism of Action
N0000009917,Adrenergic alpha1-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009917,,,,,,,Mechanism of Action
N0000020026,Phosphodiesterase 5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020026,,,,,,,Mechanism of Action
N0000175632,Decreased Fibrinolysis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175632,,,,,,,Physiologic Effect
N0000184145,Chloride Channel Activation Potentiators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184145,,,,,,,Mechanism of Action
N0000190118,Cytochrome P450 3A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190118,,,,,,,Mechanism of Action
N0000020074,Phosphate Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020074,,,,,,,Mechanism of Action
N0000008217,Azoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008217,,,,,,,Chemical/Ingredient
N0000175547,Reduction Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175547,,,,,,,Mechanism of Action
N0000175917,Thyroid Hormone Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175917,,,,,,,Mechanism of Action
N0000167510,"Estrogens, Conjugated (USP)",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167510,,,,,,,Chemical/Ingredient
N0000166743,Esters,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166743,,,,,,,Chemical/Ingredient
N0000182960,Phosphodiesterase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182960,,,,,,,Mechanism of Action
N0000175969,Increased Megakaryocyte Maturation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175969,,,,,,,Physiologic Effect
N0000175076,Protein Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175076,,,,,,,Mechanism of Action
N0000186778,Microsomal Triglyceride Transfer Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186778,,,,,,,Mechanism of Action
N0000000166,alpha Glucosidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000166,,,,,,,Mechanism of Action
N0000007961,"Heparin, Low-Molecular-Weight",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007961,,,,,,,Chemical/Ingredient
N0000175513,Dipeptidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175513,,,,,,,Mechanism of Action
N0000000191,Dihydrofolate Reductase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000191,,,,,,,Mechanism of Action
N0000185504,Cytochrome P450 2C9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185504,,,,,,,Mechanism of Action
N0000007570,Pyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007570,,,,,,,Chemical/Ingredient
N0000175862,Magnetic Resonance Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175862,,,,,,,Mechanism of Action
N0000191258,RNA Replicase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191258,,,,,,,Mechanism of Action
N0000175459,Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175459,,,,,,,Chemical/Ingredient
N0000178324,Increased Hematopoietic Stem Cell Mobilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178324,,,,,,,Physiologic Effect
N0000011418,Streptogramins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011418,,,,,,,Chemical/Ingredient
N0000182140,Cytochrome P450 2C19 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182140,,,,,,,Mechanism of Action
N0000175370,Cholinergic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175370,,,,,,,Mechanism of Action
N0000008553,Decreased Cholesterol Absorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008553,,,,,,,Physiologic Effect
N0000007620,Ergot Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007620,,,,,,,Chemical/Ingredient
N0000007948,Tetracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007948,,,,,,,Chemical/Ingredient
N0000000190,Histamine H1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000190,,,,,,,Mechanism of Action
N0000008330,Cardiac Rhythm Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008330,,,,,,,Physiologic Effect
N0000008054,Sulfonylurea Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008054,,,,,,,Chemical/Ingredient
N0000007770,Deoxyuridine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007770,,,,,,,Chemical/Ingredient
N0000000122,Adrenergic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000122,,,,,,,Mechanism of Action
N0000000202,beta Lactamase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000202,,,,,,,Mechanism of Action
N0000007707,Diphosphonates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007707,,,,,,,Chemical/Ingredient
N0000191423,Multidrug and Toxin Extrusion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191423,,,,,,,Mechanism of Action
N0000175965,Increased Prothrombin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175965,,,,,,,Physiologic Effect
N0000009022,Digestive/GI System Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009022,,,,,,,Physiologic Effect
N0000007530,Anthracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007530,,,,,,,Chemical/Ingredient
N0000006165,Triiodothyronine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006165,,,,,,,Chemical/Ingredient
N0000008853,Decreased RNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008853,,,,,,,Physiologic Effect
N0000175975,General Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175975,,,,,,,Physiologic Effect
N0000006014,Pyrethrins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006014,,,,,,,Chemical/Ingredient
N0000000069,Calcium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000069,,,,,,,Mechanism of Action
N0000008732,Decreased Mitosis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008732,,,,,,,Physiologic Effect
N0000000168,Selective Estrogen Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000168,,,,,,,Mechanism of Action
N0000009267,Increased Cytokine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009267,,,,,,,Physiologic Effect
N0000006320,Vasopressins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006320,,,,,,,Chemical/Ingredient
N0000011311,Monobactams,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011311,,,,,,,Chemical/Ingredient
N0000187061,Organic Cation Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187061,,,,,,,Mechanism of Action
N0000000209,Adrenergic alpha-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000209,,,,,,,Mechanism of Action
N0000007621,Ergotamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007621,,,,,,,Chemical/Ingredient
N0000175508,Lipopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175508,,,,,,,Chemical/Ingredient
N0000175702,Partial Cholinergic Nicotinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175702,,,,,,,Mechanism of Action
N0000007681,Amides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007681,,,,,,,Chemical/Ingredient
N0000182728,Potassium Channel Openers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182728,,,,,,,Mechanism of Action
N0000000236,Alkylating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000236,,,,,,,Mechanism of Action
N0000182638,HCV NS3/4A Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182638,,,,,,,Mechanism of Action
N0000007566,Benzylamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007566,,,,,,,Chemical/Ingredient
N0000178478,Increased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178478,,,,,,,Physiologic Effect
N0000009923,Adrenergic beta1-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009923,,,,,,,Mechanism of Action
N0000170118,PPAR alpha,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170118,,,,,,,Chemical/Ingredient
N0000007893,Glycosaminoglycans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007893,,,,,,,Chemical/Ingredient
N0000175445,Chemokine Co-receptor 5 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175445,,,,,,,Mechanism of Action
N0000175721,Nonsteroidal Anti-inflammatory Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175721,,,,,,,Chemical/Ingredient
N0000009945,Antidiuretic Hormone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009945,,,,,,,Mechanism of Action
N0000007606,Quinolones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007606,,,,,,,Chemical/Ingredient
N0000011402,Estradiol Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011402,,,,,,,Chemical/Ingredient
N0000166469,Thiazides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166469,,,,,,,Chemical/Ingredient
N0000009048,GI Motility Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009048,,,,,,,Physiologic Effect
N0000006290,Vitamin K,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006290,,,,,,,Chemical/Ingredient
N0000008157,Cardiac Glycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008157,,,,,,,Chemical/Ingredient
N0000191275,UGT1A3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191275,,,,,,,Mechanism of Action
N0000175550,Decreased Immunologic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175550,,,,,,,Physiologic Effect
N0000007663,Nitroimidazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007663,,,,,,,Chemical/Ingredient
N0000011161,Cephalosporins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011161,,,,,,,Chemical/Ingredient
N0000175685,Partial Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175685,,,,,,,Mechanism of Action
N0000175372,Appetite Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175372,,,,,,,Physiologic Effect
N0000007889,Glycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007889,,,,,,,Chemical/Ingredient
N0000009982,Decreased Sebaceous Gland Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009982,,,,,,,Physiologic Effect
N0000008556,Decreased Coagulation Factor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008556,,,,,,,Physiologic Effect
N0000175085,Microtubule Inhibition,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175085,,,,,,,Physiologic Effect
N0000000194,Somatostatin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000194,,,,,,,Mechanism of Action
N0000190855,Vesicular Monoamine Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190855,,,,,,,Mechanism of Action
N0000009065,Hematologic Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009065,,,,,,,Physiologic Effect
N0000184143,Carbamoyl Phosphate Synthetase 1 Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184143,,,,,,,Mechanism of Action
N0000175733,Neuromuscular Depolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175733,,,,,,,Physiologic Effect
N0000175436,Neuraminidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175436,,,,,,,Mechanism of Action
N0000191266,Cytochrome P450 1A2 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191266,,,,,,,Mechanism of Action
N0000007246,Estradiol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007246,,,,,,,Chemical/Ingredient
N0000007706,Prostaglandins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007706,,,,,,,Chemical/Ingredient
N0000000196,GABA A Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000196,,,,,,,Mechanism of Action
N0000175542,M2 Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175542,,,,,,,Mechanism of Action
N0000175624,mTOR Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175624,,,,,,,Mechanism of Action
N0000175955,5-Lipoxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175955,,,,,,,Mechanism of Action
N0000182141,Cytochrome P450 3A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182141,,,,,,,Mechanism of Action
N0000190115,Cytochrome P450 3A5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190115,,,,,,,Mechanism of Action
N0000175361,Catecholamine Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175361,,,,,,,Mechanism of Action
N0000175460,Non-Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175460,,,,,,,Chemical/Ingredient
N0000010258,X-Ray Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010258,,,,,,,Mechanism of Action
N0000007672,Polyenes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007672,,,,,,,Chemical/Ingredient
N0000020000,Receptor Tyrosine Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020000,,,,,,,Mechanism of Action
N0000175735,Decreased Striated Muscle Tone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175735,,,,,,,Physiologic Effect
N0000007556,Dihydropyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007556,,,,,,,Chemical/Ingredient
N0000009034,Emesis Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009034,,,,,,,Physiologic Effect
N0000008663,Decreased Immunologically Active Molecule Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008663,,,,,,,Physiologic Effect
N0000175761,Monoamine Oxidase-B Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175761,,,,,,,Mechanism of Action
N0000190110,Organic Anion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190110,,,,,,,Mechanism of Action
N0000175084,Gonadotropin Releasing Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175084,,,,,,,Mechanism of Action
N0000009916,Lipase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009916,,,,,,,Mechanism of Action
N0000007683,Organometallic Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007683,,,,,,,Chemical/Ingredient
N0000175976,Local Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175976,,,,,,,Physiologic Effect
N0000175456,Chloride Channel Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175456,,,,,,,Mechanism of Action
N0000000111,Folic Acid Metabolism Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000111,,,,,,,Mechanism of Action
N0000009079,Increased Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009079,,,,,,,Physiologic Effect
N0000185503,P-Glycoprotein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185503,,,,,,,Mechanism of Action
N0000175964,Vitamin K Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175964,,,,,,,Mechanism of Action
N0000175982,Reversed Anticoagulation Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175982,,,,,,,Physiologic Effect
N0000175629,Increased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175629,,,,,,,Physiologic Effect
N0000166489,Quaternary Ammonium Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166489,,,,,,,Chemical/Ingredient
N0000191277,UGT1A6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191277,,,,,,,Mechanism of Action
N0000007700,Retinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007700,,,,,,,Chemical/Ingredient
N0000009010,Decreased Tracheobronchial Stretch Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009010,,,,,,,Physiologic Effect
N0000190107,Organic Anion Transporting Polypeptide 1B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190107,,,,,,,Mechanism of Action
N0000000109,Serotonin Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000109,,,,,,,Mechanism of Action
N0000020060,DNA Polymerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020060,,,,,,,Mechanism of Action
N0000009918,Adrenergic alpha2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009918,,,,,,,Mechanism of Action
N0000008867,Decreased Respiratory Secretion Viscosity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008867,,,,,,,Physiologic Effect
N0000020019,Glucosylceramide Synthase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020019,,,,,,,Mechanism of Action
N0000008118,Xanthines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008118,,,,,,,Chemical/Ingredient
N0000182147,Sigma-1 Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182147,,,,,,,Mechanism of Action
N0000000144,Iron Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000144,,,,,,,Mechanism of Action
N0000008841,Decreased Protein Synthesis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008841,,,,,,,Physiologic Effect
N0000006806,Amino Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006806,,,,,,,Chemical/Ingredient
N0000009059,Genitourinary Arterial Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009059,,,,,,,Physiologic Effect
N0000175533,Dyes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175533,,,,,,,Mechanism of Action
N0000175851,Depigmenting Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175851,,,,,,,Physiologic Effect
N0000185607,Cytochrome P450 2C19 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185607,,,,,,,Mechanism of Action
N0000175628,Decreased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175628,,,,,,,Physiologic Effect
N0000175651,Increased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175651,,,,,,,Physiologic Effect
N0000009922,Adrenergic beta2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009922,,,,,,,Mechanism of Action
N0000185507,Cytochrome P450 2C9 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185507,,,,,,,Mechanism of Action
N0000175650,Decreased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175650,,,,,,,Physiologic Effect
N0000191269,UDP Glucuronosyltransferases Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191269,,,,,,,Mechanism of Action
N0000175472,Metal Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175472,,,,,,,Mechanism of Action
N0000007911,Rifamycins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007911,,,,,,,Chemical/Ingredient
N0000000125,Cholinergic Muscarinic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000125,,,,,,,Mechanism of Action
N0000181815,Sphingosine 1-Phosphate Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181815,,,,,,,Mechanism of Action
N0000007710,"Prostaglandins E, Synthetic",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007710,,,,,,,Chemical/Ingredient
N0000191276,UGT1A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191276,,,,,,,Mechanism of Action
N0000175833,Acidifying Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175833,,,,,,,Mechanism of Action
N0000009924,Adrenergic beta2-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009924,,,,,,,Mechanism of Action
N0000000243,Androgen Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000243,,,,,,,Mechanism of Action
N0000007983,Hydroxy Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007983,,,,,,,Chemical/Ingredient
N0000007883,Amphetamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007883,,,,,,,Chemical/Ingredient
N0000175968,Thrombopoietin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175968,,,,,,,Mechanism of Action
N0000175479,Amphenicols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175479,,,,,,,Chemical/Ingredient
N0000006276,Vitamin B 12,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006276,,,,,,,Chemical/Ingredient
N0000175684,Full Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175684,,,,,,,Mechanism of Action
N0000191273,UGT2B7 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191273,,,,,,,Mechanism of Action
N0000171131,Allergens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171131,,,,,,,Chemical/Ingredient
N0000182143,P2Y12 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182143,,,,,,,Mechanism of Action
N0000186774,Diarylquinolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186774,,,,,,,Chemical/Ingredient
N0000007853,Aminoglycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007853,,,,,,,Chemical/Ingredient
N0000008478,Decreased Cell Wall Integrity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008478,,,,,,,Physiologic Effect
N0000000233,Nucleic Acid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000233,,,,,,,Mechanism of Action
N0000000239,P-Glycoprotein Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000239,,,,,,,Mechanism of Action
N0000000106,Prostaglandin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000106,,,,,,,Mechanism of Action
N0000011294,Carbapenems,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011294,,,,,,,Chemical/Ingredient
N0000175442,Lincosamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175442,,,,,,,Chemical/Ingredient
N0000000246,HIV Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000246,,,,,,,Mechanism of Action
N0000181819,Uncompetitive NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181819,,,,,,,Mechanism of Action
N0000175433,pleuromutilin,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175433,,,,,,,Chemical/Ingredient
N0000175549,Cystine Disulfide Reduction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175549,,,,,,,Mechanism of Action
N0000191624,Cytochrome P450 1A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191624,,,,,,,Mechanism of Action
N0000005934,Progesterone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005934,,,,,,,Chemical/Ingredient
N0000175912,Dipeptidyl Peptidase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175912,,,,,,,Mechanism of Action
N0000185506,Cytochrome P450 3A4 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185506,,,,,,,Mechanism of Action
N0000175448,Potassium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175448,,,,,,,Mechanism of Action
N0000187058,Sodium-Glucose Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187058,,,,,,,Mechanism of Action
N0000008241,Androstanes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008241,,,,,,,Chemical/Ingredient
N0000000176,Topoisomerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000176,,,,,,,Mechanism of Action
N0000007888,Bismuth,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007888,,,,,,,Chemical/Ingredient
N0000175374,Peroxisome Proliferator-activated Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175374,,,,,,,Mechanism of Action
N0000190113,Breast Cancer Resistance Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190113,,,,,,,Mechanism of Action
N0000006337,Ergocalciferols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006337,,,,,,,Chemical/Ingredient
N0000175469,Pyrophosphate Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175469,,,,,,,Chemical/Ingredient
N0000000250,Melatonin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000250,,,,,,,Mechanism of Action
N0000175365,Bile-acid Binding Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175365,,,,,,,Mechanism of Action
N0000175730,Centrally-mediated Muscle Relaxation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175730,,,,,,,Physiologic Effect
N0000175366,Increased Diuresis at Loop of Henle,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175366,,,,,,,Physiologic Effect
N0000008010,Cannabinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008010,,,,,,,Chemical/Ingredient
N0000007658,Nitrofurans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007658,,,,,,,Chemical/Ingredient
N0000020015,NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020015,,,,,,,Mechanism of Action
N0000009909,Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009909,,,,,,,Physiologic Effect
N0000182139,Cytochrome P450 2B6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182139,,,,,,,Mechanism of Action
N0000175962,Lead Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175962,,,,,,,Mechanism of Action
N0000011301,Progesterone Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011301,,,,,,,Chemical/Ingredient
N0000008638,Decreased GnRH Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008638,,,,,,,Physiologic Effect
N0000008048,Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008048,,,,,,,Chemical/Ingredient
N0000190108,Organic Anion Transporting Polypeptide 1B3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190108,,,,,,,Mechanism of Action
N0000000100,Estrogen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000100,,,,,,,Mechanism of Action
N0000008577,Decreased DNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008577,,,,,,,Physiologic Effect
N0000175972,Decreased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175972,,,,,,,Physiologic Effect
N0000011280,Prostaglandins I,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011280,,,,,,,Chemical/Ingredient